Repurposing the dual orexin receptor antagonist suvorexant for the treatment of opioid use disorder: why sleep on this any longer?

被引：0
|
作者：
Morgan H. James
Jennifer E. Fragale
R. Nisha Aurora
Nina A. Cooperman
Daniel D. Langleben
Gary Aston-Jones
机构：
[1] Rutgers University,Brain Health Institute
[2] University of Melbourne,Florey Institute of Neuroscience and Mental Health
[3] Rutgers Robert Wood Johnson Medical School,Department of Medicine
[4] Rutgers Robert Wood Johnson Medical School,Division of Addiction Psychiatry
[5] University of Pennsylvania,Perelman School of Medicine
[6] Philadelphia VA Medical Center,undefined
来源：
Neuropsychopharmacology | 2020年 / 45卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：717 / 719
页数：2
相关论文
共 50 条
  • [1] Repurposing the dual orexin receptor antagonist suvorexant for the treatment of opioid use disorder: why sleep on this any longer?
    James, Morgan H.
    Fragale, Jennifer E.
    Aurora, R. Nisha
    Cooperman, Nina A.
    Langleben, Daniel D.
    Aston-Jones, Gary
    [J]. NEUROPSYCHOPHARMACOLOGY, 2020, 45 (05) : 717 - 719
  • [2] Suvorexant: A Dual Orexin Receptor Antagonist for the Treatment of Sleep Onset and Sleep Maintenance Insomnia
    Patel, Kunal V.
    Aspesi, Anthony V.
    Evoy, Kirk E.
    [J]. ANNALS OF PHARMACOTHERAPY, 2015, 49 (04) : 477 - 483
  • [3] Development of the manufacturing route for suvorexant - a dual orexin antagonist for sleep disorder
    Wallace, Debra J.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [4] Promotion of Sleep by Suvorexant--A Novel Dual Orexin Receptor Antagonist
    Winrow, Christopher J.
    Gotter, Anthony L.
    Cox, Christopher D.
    Doran, Scott M.
    Tannenbaum, Pamela L.
    Breslin, Michael J.
    Garson, Susan L.
    Fox, Steven V.
    Harrell, Charles M.
    Stevens, Joanne
    Reiss, Duane R.
    Cui, Donghui
    Coleman, Paul J.
    Renger, John J.
    [J]. JOURNAL OF NEUROGENETICS, 2011, 25 (1-2) : 52 - 61
  • [5] Dual Orexin-Receptor Antagonist Effects on Sleep, Opioid Withdrawal, and Craving in Persons With Opioid Use Disorder
    Huhn, Andrew
    [J]. NEUROPSYCHOPHARMACOLOGY, 2021, 46 (SUPPL 1) : 22 - 22
  • [6] The dual orexin receptor antagonist suvorexant in alcohol use disorder and comorbid insomnia: A case report
    Campbell, Erin J.
    Bonomo, Yvonne
    Collins, Lisa
    Norman, Amanda
    O'Neill, Helen
    Streitberg, Amanda
    Galloway, Kate
    Kyoong, Andrew
    Perkins, Andrew
    Pastor, Adam
    Lawrence, Andrew J.
    [J]. CLINICAL CASE REPORTS, 2024, 12 (05):
  • [7] SUVOREXANT Dual Orexin OX1/OX2 Receptor Antagonist Treatment of Sleep Disorders
    Radl, S.
    [J]. DRUGS OF THE FUTURE, 2013, 38 (01) : 27 - 36
  • [8] Suvorexant, a Novel Dual Orexin Receptor Antagonist, for the Management of Insomnia
    Han, Andrew H.
    Burroughs, Caroline R.
    Falgoust, Evan P.
    Hasoon, Jamal
    Hunt, Grace
    Kakazu, Juyeon
    Lee, Tim
    Kaye, Adam M.
    Kaye, Alan D.
    Ganti, Latha
    [J]. HEALTH PSYCHOLOGY RESEARCH, 2022, 10 (05):
  • [9] Laboratory and practical synthesis of Suvorexant, a selective dual orexin receptor antagonist
    Minehira, Daisuke
    Takahara, Satoyuki
    Adachi, Isao
    Toyooka, Naoki
    [J]. TETRAHEDRON LETTERS, 2014, 55 (42) : 5778 - 5780
  • [10] The Dual Orexin Receptor Antagonist Suvorexant Reduces Cocaine Motivation and Normalizes Sleep Disturbances During Abstinence
    Gyawali, Utsav
    O'Connor, Shayna
    Merai, Shuchi
    Paladino, Morgan
    Krishnakumar, Nivedita
    Bilotti, Michelle
    Olson, Charlie
    Barker, David
    James, Morgan
    [J]. NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 464 - 465
12345